| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC3833 |
| Trial ID | NCT06347068 |
| Disease | Breast Cancer | Triple Negative Breast Cancer |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | iC9-CAR.B7-H3 T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Study of Administration of T Cells Expressing B7-H3 Specific Chimeric Antigen Receptors and Containing the Inducible Caspase 9 Safety Switch in Subjects With Triple Negative Breast Cancer |
| Year | 2024 |
| Country | United States |
| Company sponsor | UNC Lineberger Comprehensive Cancer Center |
| Other ID(s) | LCCC2128-ATL |
| Cohort 1 | |||||||||||
|
|||||||||||